|
Clinical Study of Intermittent Positive Pressure Breathing (IPPB) Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Clinical Study of Intermittent Positive Pressure Breathing (IPPB) conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Clinical Study of Intermittent Positive Pressure Breathing (IPPB) Clinical research trials and Clinical Study of Intermittent Positive Pressure Breathing (IPPB) health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Clinical Study of Intermittent Positive Pressure Breathing (IPPB). Clinical Study of Intermittent Positive Pressure Breathing (IPPB) Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Clinical Study of Intermittent Positive Pressure Breathing (IPPB) clinical trial. Human subjects often get the best healthcare possible for their Clinical Study of Intermittent Positive Pressure Breathing (IPPB) condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Clinical Study of Intermittent Positive Pressure Breathing (IPPB)  Clinical Study of Intermittent Positive Pressure Breathing (IPPB)
Clinical Study of Intermittent Positive Pressure Breathing (IPPB)
For Condition: Lung Diseases,Lung Diseases, Obstructive,Chronic Obstructive Pulmonary Disease
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To evaluate the efficacy of long-term intermittent positive pressure breathing (IPPB) treatment when used as an adjunct to the overall care of ambulatory outpatients with chronic obstructive pulmonary disease. The evaluation compared the use of IPPB with use of a powered nebulizer.
Details: BACKGROUND: Intermittent positive pressure breathing may be a useful adjunct therapy for patients with chronic obstructive pulmonary disease. It is, however, quite expensive; moreover, in 1976 its treatment efficacy had not been determined. Although the effectiveness of IPPB had been previously studied, the influence of long-term treatment was not known for the following reasons: The individuals studied had been too few and were not randomly assigned to treatment groups, the patient groups were not homogeneous and their clinical and functional status were not well-documented, and precise descriptions of the manner in which IPPB was administered were not recorded. Based on these facts, a conference on the Scientific Basis of Respiratory Therapy, co-sponsored by the American Thoracic Society and the Division of Lung Diseases, issued a recommendation to develop a controlled clinical study of IPPB. Contracts were awarded to five clinical centers and a data center in November 1976. Planning of the trial ended in November 1977. Recruitment began in April 1978 for the 985 individuals who took part in this trial and ended in October 1980. Patients enrolled after March 31, 1980, were followed for 30 months instead of 36 months. Follow-up was completed in May 1983. DESIGN NARRATIVE: Randomized, fixed sample of 985 patients. Eligible patients were assigned to a treatment group using intermittent positive pressure breathing or to a control group using a powered nebulizer for treatment 3-4 times a day. Treatments continued for 3 years. Endpoints related to quality of life and respiratory function and capability.
Eligibility:
Study Type: Interventional, Treatment, Randomized
Minimum Age/Maximum Age: 30 Years/74 Years
Genders: Both
Protocol Entry Criteria: Men and women, ages 30 to 74, who were ambulatory and had symptomatic chronic bronchitis or emphysema.
Total Enrollment:
Location and Contact Information:
Overall Study Official:
NicholasAnthonisen, , University of Manitoba
Additional Information:
Study ID Numbers: 203;
Study Start Date: November 1976
Record last reviewed: May 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000565
Other Lung Diseases, Obstructive Studies:
1. Diet and Chronic Obstructive Pulmonary Disease
2. Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
3. Specialized Center of Research in Occupational and Immunologic Lung Disease
4. Effectiveness and Cost Impact of a Telecommunications System in COPD
5. Genetics of Airway Responsiveness and Lung Function
Related Studies:
Other Lung Diseases, Obstructive Clinical Trials
Other Clinical Trials
Other Clinical Trials
Clinical Study of Intermittent Positive Pressure Breathing (IPPB)
|
|
|
|
|
|
|
|
